Delivery Order SPE2DB20D3101-SPE2DB24FREC9
Award Date 3/15/24
Potential Completion Date 3/18/24
Potential Value $4.7K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Advair HFA 115-21 MCG Inhaler, 12GM to the Defense Logistics Agency (DLA). The contract, valued at $1,561.98, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order with a firm fixed price and a completion date of January 30, 2024. The contract does not have a set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor. The contract has a ceiling value of $5,776.91 and is a Firm Fixed Price Delivery Order with an ultimate completion date of May 7, 2024. The contract was awarded on May 6, 2024 and does not have a set-aside designation,...
- This federal contract award is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., as a firm fixed-price delivery order. The contract has a ceiling value of $3,853.72 and an ultimate completion date of February 27, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM to the Medical Supply Chain, a division of the Defense Logistics Agency (DLA). The $22,887.79 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 1, 2024, with a completion date of March 4, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The federal contract award is for the delivery of Advair HFA 230-21 MCG inhalers, with a ceiling value of $1,573.29. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. This contract is a delivery order, with a firm fixed-price pricing type, and does not have a set-aside designation. The period of performance runs from the award...
- This federal contract award is for the delivery of Advair HFA 45-21 MCG inhalers to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 7, 2024, with a completion date of February 8, 2024. The contract has a ceiling value of $1,335.71 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which...
- This federal contract award provides for the delivery of Advair HFA 230-21 MCG inhalers to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The $4,369.96 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 11, 2024 with an ultimate completion date of July 12, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
- This federal contract award is for the delivery of Advair HFA 230-21 MCG Inhaler 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,987.86 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 22, 2024, with a completion date of July 23, 2024. The contract does not have a set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of Advair HFA 230-21 MCG Inhaler 12GM to the Medical Supply Chain division of the Defense Logistics Agency (DLA). The $11,217.14 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. This contract does not have a set-aside designation. The award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support...
- This federal contract award is for the delivery of Advair HFA 230-21 mcg inhalers to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The 12-month, firm fixed price contract, valued at $5,886.79, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery...